EU Research Commissioner Carlos Moedas sent the European Parliament and member states a €94.1 billion research budget proposal on Thursday outlining increases in basic science spending and a blueprint for a new innovation council to spawn transformative inventions.
The Commission’s budget breakdown for its next research programme, Horizon Europe, running between 2021 and 2027, devotes the biggest share of funding, €52.7 billion, to a series of projects to tackle climate change, boost digital technologies, improve food, handle other ‘global challenges’ and boost industrial competitiveness.
The balance of the €94.1 billion will go to fund fundamental science and innovation. The total for Horizon Europe represents about 10 per cent of government research funding across the EU.
“We’re aiming higher than ever,” the Commissioner said in an interview Wednesday. Horizon Europe follows the current Horizon 2020, which has provided around €77 billion in research funding. From the start, its competitions have been extremely popular and sometimes heavily over-subscribed.
Moedas is obviously thrilled about the proposed funding increase, which comes at the expense of EU investment in agriculture and poorer regions, the two main staples of the Brussels budget.
His colleagues can’t help but feel a little envious of the budget increase. One commissioner, riding a lift with some journalists in the Berlaymont on Wednesday, said: “When he goes to countries, he goes with money, while I go to issue moral imperatives.” Another, vice-president Jyrki Katainen, said on Thursday that Moedas was “lucky” to have his hands on the portfolio at this moment.
All the numbers announced by Moedas assume no contribution from the UK, although the country has expressed a wish to access the next EU research programme after it has left the EU next March, in exchange for a membership fee, and a large say in how priorities are set. Membership has still to be negotiated, though.
He promises several novelties in Horizon Europe, including ‘moonshot’ missions and new rules to ease foreign access.
Missions, which are not specified in the programme, will get somewhere between €5 – €10 billion, the Commissioner said. “It’s very difficult to create missions today for 2021-2027. So we are just going to set down criteria,” Moedas said. “It would be a little bit arrogant to define the missions now.”
Nevertheless, he gave two examples of possible missions that he feels the European public would get behind and support: finding a cure for Alzheimer’s disease, and creating zero-carbon boats.
The desire to create missions is also borne out of a niggling feeling the Commissioner has that there is not enough awareness or credit today for EU-funded research. “When IMI [the EU-funded Innovative Medicines Initiative] helped create a new Ebola vaccine in 2015, nobody knew it was us,” Moedas said.
Brussels also wants to tighten and, in its words, streamline the management of public-private research partnerships. “We have too many names, too many acronyms,” Moedas said.
Some ingenuity with numbers means the Commission is claiming a total research budget of €100 billion.
Image Credit: EC Horizon 2020
News This Week
NanoApps Medical is investigating the possibility that superparamagnetic nanoparticles (SPIONs) and other classes of nanoparticles (e.g., gold coated nanoshells) might have the capacity to target cancerous tumors, metastasizing cancer cells, pathogens, etc. to deactivate/eliminate [...]
If a little humanoid robot begged you to not shut it off, would you show compassion? In an experiment designed to investigate how people treat robots when they act like humans, many participants struggled [...]
Artificial intelligence and machine learning tools have the potential to analyze large datasets and extract meaningful insights to enhance patient outcomes, an ability that is proving helpful in radiology and pathology. Images obtained by [...]
Researchers at the University of East Anglia have developed a new nanoparticle-based cancer therapy to deliver a combination therapy directly to cancer cells. The new therapy, which has been demonstrated to make prostate cancer [...]
When Joe Rubinsztain started gMed, he was admittedly young—only a few years removed from medical school— and he just didn’t understand leadership that well. “I needed to be abreast of everything and understand everything [...]
Healthcare organizations are likely to see a rapidly growing market around artificial intelligence tools for medical imaging, a new report predicts. The market for artificial intelligence (AI) tools to process and analyze medical imaging [...]
Tuberculosis, a bacterial disease which predominantly affects the lungs, isn’t all that common a sight in the United States. On average, fewer than 10,000 cases are reported each year in a country with [...]
Implantation of a stent-like flow diverter can offer one option for less invasive treatment of brain aneurysms – bulges in blood vessels – but the procedure requires frequent monitoring while the vessels heal. Now, [...]